New EQA for 2020: Prediction of 5-Fluorouracil Toxicity (Testing of DPYD variants)
14 July 2020
GenQA are delighted to open registration for our latest new EQA. This pilot EQA is open for all laboratories offering DPYD testing to predict toxicity in patients treated with 5-fluorouracil (5-FU) based chemotherapy.
For full details see https://www.genqa.org/eqa/687
Three DNA samples will be provided for analysis in October 2020, with four weeks for analysis.
If you are interested in participating in this EQA but are not yet a member of GenQA, then please register to join GenQA.